Structural equation modelling the relationship between anti-fungal prophylaxis and Pseudomonas bacteremia in ICU patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-425X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Structural equation modelling the relationship between anti-fungal prophylaxis and Pseudomonas bacteremia in ICU patients ; volume:10 ; number:1 ; day:21 ; month:1 ; year:2022 ; pages:1-17 ; date:12.2022
Intensive Care Medicine Experimental ; 10, Heft 1 (21.1.2022), 1-17, 12.2022
- Urheber
-
Hurley, James C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40635-022-00429-8
- URN
-
urn:nbn:de:101:1-2022050109225165136788
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hurley, James C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Emerging Antifungal Resistance in Fungal Pathogens
Choosing the Right Antifungal Agent in ICU Patients
Optimization of Antifungal Prophylaxis in Haematological High-Risk Patients
Role of Antifungal Prophylaxis in Invasive Fungal Infection in Children with Acute Lymphoblastic Leukemia—A Retrospective Cross-Sectional Study
Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study
How to treat fungal infections in ICU patients
Antifungal management in ICU: careful follow-up of voriconazole prescription needed!
Challenges in investigating “Gut barrier dysfunction and bacterial translocation in ICU-acquired bacteremia”
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia
Antifungal Resistance Profile of Fungal Isolates from Fungal Rhinosinusitis Patients: A Study from Tertiary Care Hospital
Emerging Antifungal Resistance in Fungal Pathogens
Choosing the Right Antifungal Agent in ICU Patients
Optimization of Antifungal Prophylaxis in Haematological High-Risk Patients
Role of Antifungal Prophylaxis in Invasive Fungal Infection in Children with Acute Lymphoblastic Leukemia—A Retrospective Cross-Sectional Study
Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study
How to treat fungal infections in ICU patients
Antifungal management in ICU: careful follow-up of voriconazole prescription needed!
Challenges in investigating “Gut barrier dysfunction and bacterial translocation in ICU-acquired bacteremia”
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia
Antifungal Resistance Profile of Fungal Isolates from Fungal Rhinosinusitis Patients: A Study from Tertiary Care Hospital
Emerging Antifungal Resistance in Fungal Pathogens
Choosing the Right Antifungal Agent in ICU Patients
Optimization of Antifungal Prophylaxis in Haematological High-Risk Patients
Role of Antifungal Prophylaxis in Invasive Fungal Infection in Children with Acute Lymphoblastic Leukemia—A Retrospective Cross-Sectional Study
Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study
How to treat fungal infections in ICU patients
Antifungal management in ICU: careful follow-up of voriconazole prescription needed!
Challenges in investigating “Gut barrier dysfunction and bacterial translocation in ICU-acquired bacteremia”
COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia